Noninvasive Tests to Assess Liver Stiffness in Patients with Chronic Hepatitis B: APRI, FIB-4, and FIB-5 Scores

Basit Öğe Kaydı
dc.authoridYAKUT, AYSUN/0000-0001-7792-8438
dc.contributor.authorYakut, Aysun
dc.contributor.authorAladag, Murat
dc.date.accessioned2025-10-24T18:09:27Z
dc.date.available2025-10-24T18:09:27Z
dc.date.issued2024
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractBackground. Invasive percutaneous liver parenchymal biopsy is the best test used to evaluate liver stiffness and fibrosis in the follow-up and treatment of chronic hepatitis B (CHB) patients. In this study, we aimed to indirectly evaluate the severity of liver parenchymal fibrosis with tests used in the laboratory. Methods. This retrospective study was conducted with 201 patients diagnosed with CHB who underwent liver biopsy between 2021 and 2022. Preprocedural examination information, laboratory tests, and histopathological data of the patients were taken from the hospital database and examined. Aspartate aminotransferase (AST)-platelet ratio index (APRI), 4 factor-based fibrosis index (FIB-4) score, and 5 factor-based fibrosis index (FIB-5) score were calculated and compared with liver histopathological features. Results. Of the 201 CHB patients, 76 were females and 125 were males. The average age of the patients was 38.05 +/- 12.63 years. A weak, statistically significant correlation was observed between FIB-4 and APRI scores. The patients' significant fibrosis scores were 31.3% and 33.8%, respectively (r = 0.313; r = 0.338; p=0.001; p<0.01). The very weak negative correlation of 17.4% between the patients' FIB-5 score and fibrosis score was statistically significant (r = -0.174; p=0.014; p<0.05). Conclusions. According to the data we obtained in our study, while the APRI score and FIB-4 score can be used safely, more comprehensive studies are needed for the reliability of the FIB-5 score.
dc.identifier.doi10.1155/2024/5540648
dc.identifier.issn1368-5031
dc.identifier.issn1742-1241
dc.identifier.urihttps://doi.org/10.1155/2024/5540648
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3657
dc.identifier.volume2024
dc.identifier.wosWOS:001273360700001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofInternational Journal Of Clinical Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20251023
dc.subjectTransient Elastography; Virus-Infection; Blood-Tests; Fibrosis; Biopsy; Markers; Index; Aminotransferase; Diagnosis; Aspartate
dc.titleNoninvasive Tests to Assess Liver Stiffness in Patients with Chronic Hepatitis B: APRI, FIB-4, and FIB-5 Scores
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu